SC 13G Filing

Company

Theriva Biologics, Inc.

Filed

December 8, 2006

Accession Number

0001012975-06-000485

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →